Modulation of epidermal differentiation, tissue inflammation, and T‐lymphocyte infiltration in psoriatic plaques by topical calcitriol
- 1 October 1996
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 23 (5) , 419-430
- https://doi.org/10.1111/j.1600-0560.1996.tb01431.x
Abstract
Psoriasis is characterized by immune activation, increased proliferation and abnormal differentiation of keratinocytes. The reported anti‐psoriatic mechanisms of action in vivo of vitamin D analogues include reduction of keratinocyte proliferation and induction of keratinocyte terminal differentiation. We investigated whether the anti‐psoriatic effect of the natural active vitamin D analogue, calcitriol, applied topically, is due to direct effects on keratinocytes alone or also due to immunoregulatory effects of calcitriol. Psoriasis patients were treated with topical calcitriol (0.005%) and a vehicle control for 8 weeks. Disease activity was assessed by a severity index and quantitative histopathological markers. In vitro studies of lymphocyte proliferation and gamma interferon secretion and of keratinocyte proliferation complemented the clinicohistopathologic studies. A heterogeneous response to calcitriol treatment could be segregated based upon elimination of K‐16 keratin expression. Calcitriol treatment decreased keratinocyte proliferation, normalized keratinocyte differentiation and decreased immune activation in plaques. The histologic response to vitamin D treatment of psoriasis includes suppression of both immune and keratinocyte activation in situ. These studies provide a basis for rational combination of anti‐psoriatic treatments and for the design of new vitamin D analogues to treat psoriasis.Keywords
This publication has 51 references indexed in Scilit:
- Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: A clinical and pathologic studyJournal of the American Academy of Dermatology, 1995
- CalcipotriolDrugs, 1992
- Intralesional cyclosporine in the treatment of psoriasis: A clinical, immunologic, and pharmacokinetic studyJournal of the American Academy of Dermatology, 1990
- Will 1,25-dihydroxyvitamin D3, MC 903, and their analogues herald a new pharmacologic era for the treatment of psoriasis?Archives of Dermatology, 1989
- Epidermal Keratiocytes Express the Adhesion Molecule Intercellular Adhesion Molecule-1 in Inflammatory Dermatoses.Journal of Investigative Dermatology, 1989
- The immunobiology ofvitamin D: William F.C. RigbyImmunology Today, 1988
- 1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally.Journal of Clinical Investigation, 1988
- Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous LeprosyNew England Journal of Medicine, 1986
- Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free mediaJournal of Tissue Culture Methods, 1985
- 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.Journal of Clinical Investigation, 1984